TheraCryf approves £1.05m capital raise and share-capital reorganisation
TheraCryf confirmed on 7 September 2026 that shareholders approved its approximately £1.05m gross capital raise and the related subdivision of share capital. Shares and dates The placing and subscription will issue 583,333,328 new ordinary shares. Admission is expected on 9 September, after the subdivision record time of 6pm on 8 September. Each existing 0.25p ordinary share becomes one 0.05p ordinary share plus four 0.05p deferred shares. The deferred shares have no voting or dividend rights an
0